Peter A. Thompson M.D., FACPPeter A. Thompson, M.D., FACP, is one of our founders and has served as our president and chief executive officer since May 2002, as our treasurer since December 2002, as a member of our board of directors since February 2002, and as the chairman of our board of directors since March 2006. From 2003 to 2006, Dr. Thompson served as a venture partner at ATP Capital, a venture capital firm. Previously, Dr. Thompson served as chief executive officer and chairman of the board of directors of iMetrikus, a healthcare technology company, which he co-founded. Prior to iMetrikus, Dr. Thompson served as vice president and general manager of Chiron Informatics, and prior to Chiron, he served as vice president, research and technology development at Becton Dickinson Immunocytometry Systems. Dr. Thompson is a board certified medical oncologist and internist who received an M.D. and a Sc.B. from Brown University. In 2007, Dr. Thompson received the distinguished Ernst & Young Entrepreneur Of The Year award in the Pacific Northwest Region, in the category of Life Sciences.
Kendall Mohler Ph.D.Kendall M. Mohler, Ph.D., is one of our founders and has served as our senior vice president of research and development since November 2002. From November 2002 to July 2004, he served as a member of our board of directors. From 2001 to 2002, Dr. Mohler served as vice president of biological sciences at Immunex Corporation. Dr. Mohler received a Ph.D. from the University of Texas Health Science Center and a B.S. from the University of Kansas.
Scott C. Stromatt M.D.Dr. Stromatt has served as our Senior Vice President and Chief Medical Officer since August 2008. Prior to joining Trubion, Dr. Stromatt held several senior management positions at Cell Therapeutics, most recently serving as Executive Vice President, Clinical Development and Regulatory Affairs. Prior to Cell Therapeutics, Dr. Stromatt was an employee of Northwest Biotherapeutics Inc., where he held the position of Vice President of Clinical Research and Chief Medical Officer. His earlier positions included: Senior Vice President at CE Unterberg Tobin, an investment bank, consultant to a variety of biotechnology and pharmaceutical firms, Vice President of Clinical Research at Synergen, and Director of Medical Affairs at Searle Pharmaceuticals. Dr. Stromatt received an M.D. from the University of Chicago and an MBA and B.A. from the University of Colorado.
Kathleen M. DeeleyKathleen M. Deeley has served as our senior vice president, general counsel and corporate secretary since June 2007. Prior to joining Trubion, she was founder and manager of Somerset Consulting LLC, a firm providing business and legal consulting services to biotechnology and information technology companies. From 1995 until 2005, Ms. Deeley held several positions at Corixa Corporation including corporate attorney, director of legal affairs and senior vice president, general counsel and secretary. Before joining Corixa, she practiced law at Perkins Coie LLP in Seattle, Washington. Ms. Deeley graduated from the University of California, Davis and received her J.D. from the University of Washington.
Michelle BurrisMichelle G. Burris has served as our senior vice president and chief financial officer since February 2006. From August 2005 to January 2006, Ms. Burris served as senior vice president and chief financial officer of Dendreon Corporation. From 1995 to 2005, Ms. Burris was an employee of Corixa Corporation, where she last served as senior vice president and chief financial officer. Ms. Burris is a member of the board of directors of Sonus Pharmaceuticals, which she joined in 2004. Ms. Burris received an MBA and a Post Graduate Certificate in accounting from Seattle University and a B.S. from George Mason University.
Copyright 2002–2008 Trubion Pharmaceuticals Inc. All rights reserved.

